These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10598482)

  • 1. [Cefotaxime in sequential therapy of community acquired pneumonia].
    Wolska-Goszka L; Petlak A; Słomiński JM
    Pol Merkur Lekarski; 1999 Sep; 7(39):99-101. PubMed ID: 10598482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost-effectiveness analysis of ceftriaxone and cefotaxime in the treatment of community-acquired pneumonia].
    García-Contreras F; Del-Angel-García G; Ramírez Cuenca A; Malváez-Valdes M; Vega Yáñez A; Amato D
    Rev Invest Clin; 2000; 52(4):418-26. PubMed ID: 11061104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
    Welte T; Petermann W; Schürmann D; Bauer TT; Reimnitz P;
    Clin Infect Dis; 2005 Dec; 41(12):1697-705. PubMed ID: 16288390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations.
    Wilson WR; Bouza E; Lode H; Mouton Y
    J Chemother; 1997 May; 9 Suppl 2():5-18. PubMed ID: 9248972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Community acquired pneumonia: from intravenous to oral cephalosporin sequential therapy].
    Fernández P; San Martín L
    Rev Med Chil; 2000 Mar; 128(3):267-72. PubMed ID: 10962867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Levofloxacin versus beta-lactamic therapy in community acquired pneumonia that requires hospitalization].
    Geijo Martínez MP; Díaz de Tuesta Chow-Quan AM; Herranz CR; Gómez Criado C; Dimas Nuñez JF; Saiz García F
    An Med Interna; 2002 Dec; 19(12):621-5. PubMed ID: 12593029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients.
    Parrish AG
    S Afr Med J; 1998 Sep; 88(9):1046, 1048; author reply 1050-1. PubMed ID: 9798485
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative assessment of efficacy of the 3d generation cephalosporins, ceftriabol, and claforan, in patients with community-acquired pneumonia].
    Vakhrushev IaM; Starodubtseva OI
    Klin Med (Mosk); 2009; 87(7):53-5. PubMed ID: 19705794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The choice of antibacterial drugs.
    Med Lett Drugs Ther; 1998 Mar; 40(1023):33-42. PubMed ID: 9549552
    [No Abstract]   [Full Text] [Related]  

  • 11. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
    Ortiz-Ruiz G; Caballero-Lopez J; Friedland IR; Woods GL; Carides A;
    Clin Infect Dis; 2002 Apr; 34(8):1076-83. PubMed ID: 11914996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
    File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O
    J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimation of the clinical and pharmacoeconomic efficiency of treatment in patients with community-acquired pneumonia with third-generation cephalosporins].
    Starodubtseva OI; Vakhrushev IaM
    Probl Tuberk Bolezn Legk; 2009; (6):28-9. PubMed ID: 19642570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic treatment of community acquired pneumonia varies widely across Germany.
    Kohlhammer Y; Raspe H; Marre R; Suttorp N; Welte T; Schäfer T;
    J Infect; 2007 May; 54(5):446-53. PubMed ID: 17007933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Community-acquired pneumonia in hospitalized adult patients. Clinical presentation and prognostic factors].
    Saldías F; Mardónez JM; Marchesse M; Viviani P; Farías G; Díaz A
    Rev Med Chil; 2002 Dec; 130(12):1373-82. PubMed ID: 12611238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
    Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
    Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
    File TM; Milkovich G; Tennenberg AM; Xiang JX; Khashab MM; Zadeikis N
    Curr Med Res Opin; 2004 Sep; 20(9):1473-81. PubMed ID: 15383197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of ascitic fluid polymorphonuclear cell count determination during therapy of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Ljubicic N; Spajic D; Vrkljan MM; Altabas V; Doko M; Zovak M; Gacina P; Mihatov S
    Hepatogastroenterology; 2000; 47(35):1360-3. PubMed ID: 11100352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One drug or two? Step-down therapy after i.v. antibiotics for community-acquired pneumonia.
    Harrington Z; Barnes DJ
    Intern Med J; 2007 Nov; 37(11):767-71. PubMed ID: 17908087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.